Showing results (2641-2650 of 27,712) with videos related to
Sort By:
Pageof 2,772
Vaccine|June 2, 1998
Comparison of DNA application methods to reduce BRSV shedding in cattleR S Schrijver, J P Langedijk, G M Keil, et al.Vaccine|June 2, 1998
Safety and immunogenicity of REMUNE in HIV-infected Thai subjectsA Limsuwan, V Churdboonchart, R B Moss, et al.Vaccine|June 2, 1998
Feline immunodeficiency virus subunit vaccines that induce virus neutralising antibodies but no protection against challenge infectionW Huisman, J A Karlas, K H Siebelink, et al.Vaccine|June 2, 1998
Immunogenicity and protective role of three formulations of oral cholera vaccineT Kalambaheti, U Chaisri, P Srimanote, et al.Vaccine|June 2, 1998
Mutants of Escherichia coli heat-labile enterotoxin as an adjuvant for nasal influenza vaccineK Komase, S Tamura, K Matsuo, et al.Vaccine|June 2, 1998
Induction of mucosal and systemic immune responses by intranasal immunization using recombinant cholera toxin B subunit as an adjuvantH Y Wu, M W RussellVaccine|June 2, 1998
Immunogenicity of Plasmodium falciparum circumsporozoite protein multiple antigen peptide vaccine formulated with different adjuvantsT P Le, L W Church, G Corradin, et al.Vaccine|June 2, 1998
Immunity to mumps before and after MMR vaccination at 12 years of age in the first generation offered the two-dose immunization programmeK Broliden, E R Abreu, M Arneborn, et al.Vaccine|June 2, 1998
Antibody titers eight months after three doses of a five-valent pneumococcal conjugate vaccine in HIV and non-HIV-infected children less than two years of ageJ C King, P E Vink, I Chang, et al.Vaccine|June 2, 1998
Effect of particulation on the immunogenic and protective properties of the recombinant Bm86 antigen expressed in Pichia pastorisJ C García-García, C Montero, M Rodríguez, et al.Pageof 2,772